Louis G. Lange, Director at NewAmsterdam Pharma Co N.V. (NAMS), sold 28,186 shares at $29.41 ($829K) on 2026-03-06, disclosed to the SEC on 2026-03-10.
Open-market sale of $829k NAMS by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| BOLD | SELL | 2019-12-27 | $656K | — | Filing → |
| BOLD | SELL | 2019-09-25 | $667K | — | Filing → |
| BOLD | SELL | 2019-06-26 | $1.5M | — | Filing → |